Alright. Notice we have done our average volume for a day at 10:00- Usually that means an explosion later.... Fingers crossed
Van You Like This Name. Potentially they could spin out a bunch of medicines for some really big indications with this method of theirs....
I have noticed something new in the market. The issuing of shares which used to kill these companies worrying about dilution. This is now seen as a positive by the Robin Hood investor.
My instinct is to sell SKILZ. We have a 55% gain. Anybody have a view it's a large position and a heavy lifter in my account. I don't want to mess up but it looks overbought to me.
Plus the Hedge Fund was very snippy about the SPAC's I knew they would be. There is going to come a moment when folks discover some major doubling down by these PIPE investors.. The original thinking of SPAC's which I agreed with was that this was a way to get into a future IPO like stock without the round and rounds of financing... But that's really not happening-- some folks are being given early (white people) entry just before the SPAC announcement and it's all starting to smell fishy....
Quite frankly this stk is a dog we owned it and gave up quick--- CarParts.com up 15% after announcing launch of EV-focused shopping hub 09:37 PRTS Shares of CarParts.com are up 15% in early trading after the company announced earlier that it had launched a new dedicated shopping hub for the hybrid, plug-in hybrid, and electric vehicle community this week. "The ecommerce retailer is transforming the way drivers shop for auto parts, so naturally, building an online store for EVs and hybrids is the next big investment in the company's growth and commitment to getting drivers back on the road. In recent months, CarParts.com's product offering for EVs and hybrids has grown to include over 700,000 applications for the repair, maintenance, and enhancement of hybrids, plug-in hybrids, and EVs. Aftermarket parts are available for over 25 popular vehicle makes, including Tesla, Toyota, Honda, GMC, BMW, Ford, Lexus, Chevrolet, and more," the company stated in its press release regarding the launch.
Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World Conference, Spotlighting Anthony S. Fauci, MD, Director NIAID January 25-27, 2021 | GlobeNewswire-YIKES THAT"S RIGHT NOW!!! SEATTLE, Jan. 25, 2021 (GLOBE NEWSWIRE) --Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that Dr. Steven C. Quay, President and CEO, will speak as a panelist at the 2021 Precision Medicine World Conference "21(st) Century Precision Medicine in the Age of COVID-19" to be held virtually January 25-27, 2021. The panel topic is "Development of New SARS-CoV-2 Therapeutics." The panel begins at 11:30 am PST on January 26, 2021.<-- 1 hr!!!!!! Dr. Anthony S. Fauci will be the spotlight speaker of the event >>>>